BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25983116)

  • 1. Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells.
    Dhumale SS; Waghela BN; Pathak C
    IUBMB Life; 2015 May; 67(5):361-73. PubMed ID: 25983116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of N-Glycan Functions in Receptor for Advanced Glycation End Products V Domain through Chemical Glycoprotein Synthesis.
    Dong W; Yang X; Li X; Wei S; An C; Zhang J; Shi X; Dong S
    J Am Chem Soc; 2024 Jun; ():. PubMed ID: 38917169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Fei-Yan-Qing-Hua decoction decreases hyperinflammation by inhibiting HMGB1/RAGE signaling and promotes bacterial phagocytosis in the treatment of sepsis" [J. Ethnopharmacol. (2024 Mar 1) 321:117553].
    Zhang H; Xu G; Wu X; Xu Y; Xu L; Zou Y; Yang X; Pan L; Lei B; Mu J; Huang Q; Ma Y; Duan N; Zhang W; Zheng Y
    J Ethnopharmacol; 2024 May; 326():117978. PubMed ID: 38448280
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of receptor for advanced glycation end products in the complication and progression of various types of cancers.
    Malik P; Chaudhry N; Mittal R; Mukherjee TK
    Biochim Biophys Acta; 2015 Sep; 1850(9):1898-904. PubMed ID: 26028296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring products in cancer therapy.
    Rajesh E; Sankari LS; Malathi L; Krupaa JR
    J Pharm Bioallied Sci; 2015 Apr; 7(Suppl 1):S181-3. PubMed ID: 26015704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the receptor for advanced glycation end products gene polymorphisms and cancer risk: a systematic review and meta-analysis.
    Zhao DC; Lu HW; Huang ZH
    J BUON; 2015; 20(2):614-24. PubMed ID: 26011358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers.
    Tseng CH; Tzeng CC; Hsu CY; Cheng CM; Yang CN; Chen YL
    Eur J Med Chem; 2015 Jun; 97():306-19. PubMed ID: 26005780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sesamin on apoptosis and cell cycle arrest in human breast cancer mcf-7 cells.
    Siao AC; Hou CW; Kao YH; Jeng KC
    Asian Pac J Cancer Prev; 2015; 16(9):3779-83. PubMed ID: 25987037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo.
    Hashemzaei M; Delarami Far A; Yari A; Heravi RE; Tabrizian K; Taghdisi SM; Sadegh SE; Tsarouhas K; Kouretas D; Tzanakakis G; Nikitovic D; Anisimov NY; Spandidos DA; Tsatsakis AM; Rezaee R
    Oncol Rep; 2017 Aug; 38(2):819-828. PubMed ID: 28677813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells.
    Seo HS; Ku JM; Choi HS; Choi YK; Woo JK; Kim M; Kim I; Na CH; Hur H; Jang BH; Shin YC; Ko SG
    Oncol Rep; 2016 Jul; 36(1):31-42. PubMed ID: 27175602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1/RAGE axis in tumor development: unraveling its significance.
    Fan A; Gao M; Tang X; Jiao M; Wang C; Wei Y; Gong Q; Zhong J
    Front Oncol; 2024; 14():1336191. PubMed ID: 38529373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin-loaded solid lipid nanoparticles exhibit antitumor activity and suppress the proliferation of triple-negative MDA-MB 231 breast cancer cells: implications for invasive breast cancer treatment.
    Hatami M; Kouchak M; Kheirollah A; Khorsandi L; Rashidi M
    Mol Biol Rep; 2023 Nov; 50(11):9417-9430. PubMed ID: 37831347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy.
    Vella V; Lappano R; Bonavita E; Maggiolini M; Clarke RB; Belfiore A; De Francesco EM
    Endocr Rev; 2023 Jul; 44(4):693-723. PubMed ID: 36869790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review.
    Faruqui T; Khan MS; Akhter Y; Khan S; Rafi Z; Saeed M; Han I; Choi EH; Yadav DK
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin loaded folate targeted plasmonic silver nanoparticles for light activated chemo-photothermal therapy of DMBA induced breast cancer in Sprague Dawley rats.
    Bose P; Priyam A; Kar R; Pattanayak SP
    RSC Adv; 2020 Aug; 10(53):31961-31978. PubMed ID: 35518142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.
    Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S
    Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Application of Near-Infrared Nanomaterial-Liposome Hybrid Nanocarriers for Cancer Photothermal Therapy.
    Liang P; Mao L; Dong Y; Zhao Z; Sun Q; Mazhar M; Ma Y; Yang S; Ren W
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury.
    Rungratanawanich W; Qu Y; Wang X; Essa MM; Song BJ
    Exp Mol Med; 2021 Feb; 53(2):168-188. PubMed ID: 33568752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGE-RAGE synergy influences programmed cell death signaling to promote cancer.
    Waghela BN; Vaidya FU; Ranjan K; Chhipa AS; Tiwari BS; Pathak C
    Mol Cell Biochem; 2021 Feb; 476(2):585-598. PubMed ID: 33025314
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.